IMI2 Call 14 is now open with topics on immune diseases imaging machine learning and digital clincal trials

Call ID:   H2020-JTI-IMI2-2018-14-two-stage
Action Type: RIA – Research and Innovation Actions

Topics

• Topic 1: Targeted immune intervention for the management of non-response and relapse
• Topic 2: Non-invasive clinical molecular imaging of immune cells
• Topic 3: Development of a platform for federated and privacy-preserving machine learning in support of drug discovery 
• Topic 4: Centre of excellence – remote decentralised clinical trials 

For full details of the topics, including the budget breakdown and the General Conditions for the Call for proposals, click on the links above (which take you directly to the relevant page of the Participant Portal) or read the IMI2 Call 14 Text.

Indicative budget

• From EFPIA companies and IMI2 Associated Partners:  EUR 84 920 360
• From the IMI2 JU:  EUR 82 357 000

Key dates and deadlines

• Publication date: 15 March 2018
• Stage 1 submission start date: 15 March 2018
• Stage 1 submission deadline: 14 June 2018
• Stage 2 submission deadline: 11 December 2018